BioAdvance Funds TREVENTIS to Advance Alzheimer’s Drug Discovery

News   Aug 11, 2009

 
BioAdvance Funds TREVENTIS to Advance Alzheimer’s Drug Discovery
 
 
 

RELATED ARTICLES

What Makes Cancer Cells Metastasize?

News

Metastatic spread of tumor cells from one location in the body to another is the cause of 90 percent of cancer-related deaths.

READ MORE

Unlocking the Secrets of Ebola

News

Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

READ MORE

Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell Types

News

New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE